Drug intelligence / Profile preview

Renon

Development stage
Unknown
Lead developer
Medi-Radiopharma
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Renon is a radiopharmaceutical cold kit developed by Medi-Radiopharma for diagnostic renal imaging. The kit contains 10.0 mg of diethylenetriaminepentaacetic acid (DTPA) as the active ingredient. Upon reconstitution with sterile technetium-99m (99mTc) pertechnetate solution, it forms the 99mTc-DTPA complex (technetium Tc 99m pentetate). Administered via intravenous injection, it functions as a glomerular filtration agent that is cleared from the bloodstream by the kidneys via passive filtration. This allows for the visualization of the kidneys and urinary tract through sequential scintigraphy. It is indicated for multiple diagnostic applications, including the determination of glomerular filtration rate (GFR), evaluation of renal perfusion, assessment of renal artery stenosis, and monitoring of transplanted kidney function.

Brand names
Renon
Other names
99mTc-DTPAtechnetium Tc 99m pentetateDTPA

Beyond the preview

Go deeper on Renon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call